Investigators Workshop | Somatic Genetics of Neocortical Epilepsy: SLC35A2
Sunday, December 5, 2021
-
You may need to log in to view video on this page.
OVERVIEW:
This session investigates the impact of SLC35A2 on non-lesional neocortical epilepsy (NLNE), a difficult-to-treat epileptic disorder.
Patients with non-lesional neocortical epilepsy (NLNE) provide unique challenges for both medical therapy and pre-surgical evaluation and exhibit a worse post-operative seizure freedom rate. Conceptualizing how a focal area of the neocortex evolves into an epileptic network in the absence of a lesion is challenging. Somatic variants in the galactose transporter SLC35A2 have been identified in resected NLNE specimens, providing a paradigm shift in understanding NLNE.
This session highlights:
- Somatic genetic data on SLC35A2 in NLNE
- A review of phenotypic presentations in these cases
- A report of in vitro/in vivo studies showing how SLC35A2 variants lead to seizures
- A discussion of genomic strategies to investigate NLNE
Learning Objectives:
Following participation in this activity, participants will be able to:
- Define how somatic gene mutations occur during brain development, how they are distributed in the neocortex, and how genomics technologies can be used to discover even low frequency alleles
- Provide a comprehensive analysis of the phenotypic features of SLC35A2-associated NLNE
- Define how variants in SLC35A2 and other candidate variants might cause altered neuronal firing, synaptic connectivity, and network integrity in NLNE
Program:
Moderators: Peter B. Crino, MD, PhD
Speakers: Erin Heinzen, PharmD, PhD, Melodie R. Winawer, MD, MS, Annapurna Poduri, MD, MPH, FAES, and Philip Iffland, PhD